Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Methaqualone is a sedative-hypnotic medication that was widely prescribed during the mid-20th century. It was marketed under various brand names, including Quaalude (/ˈkweɪluːd/ KWAY-lood) and Sopor, typically containing 300 mg of methaqualone per tablet. A combination drug known as Mandrax was sold primarily in Europe, containing 250 mg of methaqualone…
History, Applications & Regions
Explore the main themes, entities and connections around Methaqualone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug quaalude states united sedative use also names quaaludes sold drugs tablet brand recreational schedule name mandrax rorer analogues used
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Methaqualone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Methaqualone | ATC code | N05CM01 (WHO) | 1.00 | infobox |
| Methaqualone | CAS Number | 72-44-6 Y | 1.00 | infobox |
| Methaqualone | ChEBI | CHEBI:6821 | 1.00 | infobox |
| Methaqualone | ChEMBL | ChEMBL282052 Y | 1.00 | infobox |
| Methaqualone | ChemSpider | 6055 Y | 1.00 | infobox |
| Methaqualone | CompTox Dashboard (EPA) | DTXSID7023279 | 1.00 | infobox |
| Methaqualone | Drug class | Sedative; Hypnotic; Anxiolytic; GABAA receptor positive allosteric modulator; Quinazolinone | 1.00 | infobox |
| Methaqualone | DrugBank | DB04833 Y | 1.00 | infobox |
| Methaqualone | ECHA InfoCard | 100.000.710 | 1.00 | infobox |
| Methaqualone | Elimination half-life | Biphasic (10–40; 20–60 hours) | 1.00 | infobox |
| Methaqualone | Formula | C16H14N2O | 1.00 | infobox |
| Methaqualone | KEGG | D00557 Y | 1.00 | infobox |
| Methaqualone | Legal status | AU: S9 (Prohibited substance) | 1.00 | infobox |
| Methaqualone | Legal status | BR: Class F2 (Prohibited psychotropics) | 1.00 | infobox |
| Methaqualone | Legal status | CA: Schedule III | 1.00 | infobox |
| Methaqualone | Legal status | DE: Anlage II (Authorized trade only, not prescriptible) | 1.00 | infobox |
| Methaqualone | Legal status | NZ: Class B -illegal to possess | 1.00 | infobox |
| Methaqualone | Legal status | UK: Class B | 1.00 | infobox |
| Methaqualone | Legal status | US: Schedule I | 1.00 | infobox |
| Methaqualone | Legal status | UN: Psychotropic Schedule II | 1.00 | infobox |
| Methaqualone | Melting point | 113 °C (235 °F) | 1.00 | infobox |
| Methaqualone | Molar mass | 250.301 g·mol−1 | 1.00 | infobox |
| Methaqualone | Pronunciation | /mɛθəˈkweɪloʊn/ | 1.00 | infobox |
| Methaqualone | Protein binding | 70–80% | 1.00 | infobox |
| Methaqualone | PubChem CID | 6292 | 1.00 | infobox |
| Methaqualone | Routes of administration | Oral, others | 1.00 | infobox |
| Methaqualone | Trade names | Quaalude, Sopor, Mandrax | 1.00 | infobox |
| Methaqualone | UNII | 7ZKH8MQW6T | 1.00 | infobox |
| Methaqualone | is a | sedative-hypnotic medication that was widely prescribed during the mid-20th century | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.